Abstract 7743: Pre-existing T cells drive durable anti-tumor immunity after oncolytic virus therapy in glioblastoma

Maxime Meylan(Dana-Farber Cancer Institute), Kai W. Wucherpfennig(Dana-Farber Cancer Institute), Alexander Ling(Centre for Quantum Technologies), Mario L. Suvà(Broad Institute), Graham L. Barlow(Dana-Farber Cancer Institute), Jason W. Pyrdol(Dana-Farber Cancer Institute), Daniel Kovarsky(Weizmann Institute of Science), Lucas Westphal(Dana-Farber Cancer Institute), Lijian Wu(Tsinghua University), Linh Dieu Nguyen(Dana-Farber Cancer Institute), Sydney Dumont(Broad Institute), Andres Santos(Center for Neuro-Oncology), Nicolas L. Gonzalez Castro(Massachusetts General Hospital), E Antonio Chiocca(Global Cancer Institute), Michel Julius(Dana-Farber Cancer Institute), Ye Tian(Dana-Farber Cancer Institute), Itay Tirosh(Weizmann Institute of Science)
Cancer Research
April 3, 2026
Cited by 0


Related Papers